S-Biomedic
A skin microbiome research company, developing pro and post-biotic ingredients from true skin commensals. Learn more
Launch date
Employees
Market cap
-
Enterprise valuation
€8—12m (Dealroom.co estimates Feb 2019.)
Company register number 0668.407.105
Antwerp Province of Antwerp (HQ)
Financials
Estimates*
EUR | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|
EBITDA | (<1m) | (<1m) | (<1m) | (<1m) | <1m | (4.3m) | - |
Profit | (<1m) | (<1m) | (1.1m) | (1.1m) | (<1m) | (6.1m) | <1m |
Date | Investors | Amount | Round |
---|---|---|---|
- | N/A | - | |
N/A | Seed | ||
€2.0m | Series A | ||
* | €2.0m | Series A | |
N/A | Early VC | ||
€1.3m | Grant | ||
N/A | Early VC | ||
* | N/A | Acquisition | |
Total Funding | €5.3m |
Related Content
Recent News about S-Biomedic
EditMore about S-Biomedic
EditDeveloper of novel therapeutics intended to establish methods to directly modulate the skin microbiome. The company's products are made by selecting beneficial bacteria that accelerate the rebalancing of a diseased microbiome and help to restore healthy skin, enabling clinicians to treat acne, eczema, rosacea, and aging.
Keywords: Pharmaceuticals and Biotechnology,
Tech stack
Tech stackLearn more about the technologies and tools that this company uses.